Comparing metabolomic and pathologic biomarkers alone and in combination for discriminating Alzheimer’s disease from normal cognitive aging

BACKGROUND: A critical and as-yet unmet need in Alzheimer disease (AD) research is the development of novel markers that can identify individuals at risk for cognitive decline due to AD. This would aid intervention trials designed to slow the progression of AD by increasing diagnostic certainty, and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Motsinger-Reif, Alison A, Zhu, Hongjie, Kling, Mitchel A, Matson, Wayne, Sharma, Swati, Fiehn, Oliver, Reif, David M, Appleby, Dina H, Doraiswamy, P Murali, Trojanowski, John Q, Kaddurah-Daouk, Rima, Arnold, Steven E
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2013
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3893491/
https://ncbi.nlm.nih.gov/pubmed/24252434
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2051-5960-1-28
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados